Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

The role of parkin in familial and sporadic Parkinson's disease.

Dawson TM, Dawson VL.

Mov Disord. 2010;25 Suppl 1:S32-9. doi: 10.1002/mds.22798. Review.

2.

Parkin: much more than a simple ubiquitin ligase.

Alves da Costa C, Checler F.

Neurodegener Dis. 2012;10(1-4):49-51. doi: 10.1159/000332803. Epub 2011 Dec 23. Review.

PMID:
22204976
3.

Parkin-associated Parkinson's disease.

von Coelln R, Dawson VL, Dawson TM.

Cell Tissue Res. 2004 Oct;318(1):175-84. Epub 2004 Jul 30. Review.

PMID:
15503153
4.

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.

Yasuda T, Mochizuki H.

Apoptosis. 2010 Nov;15(11):1312-21. doi: 10.1007/s10495-010-0486-8. Review.

PMID:
20221696
5.

Parkin and defective ubiquitination in Parkinson's disease.

Dawson TM.

J Neural Transm Suppl. 2006;(70):209-13. Review.

PMID:
17017531
6.

Parkin genetics: one model for Parkinson's disease.

Mata IF, Lockhart PJ, Farrer MJ.

Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R127-33. Epub 2004 Feb 19. Review.

PMID:
14976155
7.

The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.

Pickrell AM, Youle RJ.

Neuron. 2015 Jan 21;85(2):257-73. doi: 10.1016/j.neuron.2014.12.007. Review.

8.

New insights into Parkinson's disease.

Chung KK, Dawson VL, Dawson TM.

J Neurol. 2003 Oct;250 Suppl 3:III15-24. Review.

PMID:
14579120
9.

PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

Truban D, Hou X, Caulfield TR, Fiesel FC, Springer W.

J Parkinsons Dis. 2017;7(1):13-29. doi: 10.3233/JPD-160989. Review.

10.

How do Parkin mutations result in neurodegeneration?

Imai Y, Takahashi R.

Curr Opin Neurobiol. 2004 Jun;14(3):384-9. Review.

PMID:
15194120
11.

Activation of the E3 ubiquitin ligase Parkin.

Caulfield TR, Fiesel FC, Springer W.

Biochem Soc Trans. 2015 Apr;43(2):269-74. doi: 10.1042/BST20140321. Review.

12.

Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.

Dodson MW, Guo M.

Curr Opin Neurobiol. 2007 Jun;17(3):331-7. Epub 2007 May 11. Review.

PMID:
17499497
13.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
14.

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.

Büeler H.

Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Review.

PMID:
19303005
16.

Posttranslational modifications as versatile regulators of parkin function.

Rubio de la Torre E, Gómez-Suaga P, Martínez-Salvador M, Hilfiker S.

Curr Med Chem. 2011;18(16):2477-85. Review.

PMID:
21568911
17.

Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network.

Tanaka A.

FEBS Lett. 2010 Apr 2;584(7):1386-92. doi: 10.1016/j.febslet.2010.02.060. Epub 2010 Feb 25. Review.

18.

Pathologic and therapeutic implications for the cell biology of parkin.

Charan RA, LaVoie MJ.

Mol Cell Neurosci. 2015 May;66(Pt A):62-71. doi: 10.1016/j.mcn.2015.02.008. Epub 2015 Feb 17. Review.

19.

Parkin in the regulation of fat uptake and mitochondrial biology: emerging links in the pathophysiology of Parkinson's disease.

Kim KY, Sack MN.

Curr Opin Lipidol. 2012 Jun;23(3):201-5. doi: 10.1097/MOL.0b013e328352dc5d. Review.

20.

Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).

Zhou ZD, Sathiyamoorthy S, Angeles DC, Tan EK.

Mol Brain. 2016 Apr 18;9:41. doi: 10.1186/s13041-016-0218-2. Review.

Supplemental Content

Support Center